These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7832812)

  • 41. Abundant production of nitric oxide from murine macrophages by direct stimulation of tumor cells.
    Isobe K; Nakashima I
    Biochem Biophys Res Commun; 1993 Apr; 192(2):499-504. PubMed ID: 8484761
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
    J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Macrophage cytostatic effect on Trypanosoma musculi involves an L-arginine-dependent mechanism.
    Vincendeau P; Daulouède S
    J Immunol; 1991 Jun; 146(12):4338-43. PubMed ID: 1904079
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine.
    Lin JY; Chadee K
    J Immunol; 1992 Jun; 148(12):3999-4005. PubMed ID: 1318338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of soluble antitumoral mediators by synthetic analogues of bacterial lipoprotein in bone marrow-derived macrophages from LPS-responder and -nonresponder mice.
    Pfannes SD; Müller B; Körner S; Bessler WG; Hoffmann P
    J Leukoc Biol; 2001 Apr; 69(4):590-7. PubMed ID: 11310845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and characterization of monoclonal antibodies specific for macrophages at intermediate stages in the tumoricidal activation pathway.
    Paulnock DM; Lambert LE
    J Immunol; 1990 Jan; 144(2):765-73. PubMed ID: 2104906
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.
    Chen L; Suzuki Y; Wheelock EF
    J Immunol; 1987 Dec; 139(12):4096-101. PubMed ID: 3121728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state.
    Curley SA; Roh MS; Kleinerman E; Klostergaard J
    Lymphokine Res; 1990; 9(3):355-63. PubMed ID: 2118971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of C3H/HeJ macrophage tumoricidal activity and cytokine release by R-chemotype lipopolysaccharide preparations. Differential effects of IFN-gamma.
    Flebbe LM; Chapes SK; Morrison DC
    J Immunol; 1990 Sep; 145(5):1505-11. PubMed ID: 2117032
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of mast cell granules on the gene expression of nitric oxide synthase and tumour necrosis factor-alpha in macrophages.
    Li Y; Nguyen TD; Stechschulte AC; Stechschulte DJ; Dileepan KN
    Mediators Inflamm; 1998; 7(5):355-61. PubMed ID: 9883971
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression of murine macrophage-mediated tumor cytotoxicity induced by interferons.
    Koestler TP; Johnson WJ; Rieman D; Dalton BJ; Greig RG; Poste G
    Cancer Res; 1987 Jun; 47(11):2804-8. PubMed ID: 2436758
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor necrosis factor as a potent effector molecule for tumor cell killing by activated rat peritoneal macrophages in vitro.
    Kusenda J; Kalafut F; Klobusická M; Novotná L
    Neoplasma; 1992; 39(1):23-8. PubMed ID: 1528301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Experimental analysis of cytotoxicity mediated by activated macrophages against glioma cells in mice].
    Ohyama K
    Nihon Geka Hokan; 1993 Mar; 62(2):92-115. PubMed ID: 8239865
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
    Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
    Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of macrophage-mediated tumor cytotoxicity by pretreatment with GM-CSF.
    Heidenreich S; Gong JH; Nain M; Gemsa D
    Behring Inst Mitt; 1988 Aug; (83):274-7. PubMed ID: 3149190
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor necrosis factor is required for the priming of peritoneal macrophages by trehalose dimycolate.
    Oswald IP; Dozois CM; Fournout S; Petit JF; Lemaire G
    Eur Cytokine Netw; 1999 Dec; 10(4):533-40. PubMed ID: 10586120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct activation of murine peritoneal macrophages for nitric oxide production and tumor cell killing by interferon-gamma.
    Dileepan KN; Page JC; Li Y; Stechschulte DJ
    J Interferon Cytokine Res; 1995 May; 15(5):387-94. PubMed ID: 7648440
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages.
    Cox GW; Chattopadhyay U; Oppenheim JJ; Varesio L
    J Immunol; 1991 Dec; 147(11):3809-14. PubMed ID: 1940368
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of inducible nitric oxide synthase by Corydalis turtschaninovii on interferon-gamma stimulated macrophages.
    An HJ; Rim HK; Chung HS; Choi IY; Kim NH; Kim SJ; Moon PD; Myung NY; Jeong HJ; Jeong CH; Chung SH; Um JY; Hong SH; Kim HM
    J Ethnopharmacol; 2009 Apr; 122(3):573-8. PubMed ID: 19429329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
    Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
    Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.